Skip to main content

Advertisement

Log in

Photodynamic therapy for wound-healing modulation in pterygium surgery. A clinical pilot study

  • Short Communication
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Background

This study was performed to evaluate the safety and efficacy of photodynamic therapy with the carboxyfluorescein ester BCECF-AM as an adjunctive treatment procedure for pterygium surgery to reduce the rate of recurrence.

Methods

In this nonrandomized prospective clinical trial, 19 eyes with nasally located primary pterygium were examined. All eyes were treated with the bare sclera surgical technique. Seven eyes received in addition treatment with BCECF-AM solution and blue light. All patients were evaluated at least after 1 day, 1 week, 1 month, 3 months, and 1 year. Postoperative fibrovascular growth from the limbus of at least 1 mm was defined as recurrence.

Results

The intraoperative application of BCECF-AM solution did not cause anterior chamber flare or any other significant side effects. The bare sclera surgery rate of recurrence was 0% (zero of 12) after 3 months and 91% (11 of 12) after 1 year. The additional photodynamic therapy treatment had a rate of recurrence of 14.2% (one of seven) after 3 months and 71.4% (five of seven) after 1 year.

Conclusions

The applied PDT technique seems to be a safe procedure but is associated with a high rate of recurrence. In conclusion, the evaluated PDT treatment procedure, at this point, should not be considered. As we found a high rate of recurrence also in the control group, the bare sclera technique is not effective, even in primary pterygia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Alaniz-Camino F (1982) The use of postoperative beta radiation in the treatment of pterygia. Ophthalmic Surg 13:1022–1025

    Google Scholar 

  2. Amano S, Motoyama Y, Oshika T, Eguchi S, Eguchi K (2000) Comparative study of intraoperative mitomycin C and beta irradiation in pterygium surgery. Br J Ophthalmol 84:618–621

    Google Scholar 

  3. Anduze AL (2001) Pterygium surgery with mitomycin-C: ten-year results. Ophthalmic Surg Lasers 32:341–345

    Google Scholar 

  4. Bayer A, Mutlu FM, Sobaci G (2002) Hyperbaric oxygen therapy for mitomycin C-induced scleral necrosis. Ophthalmic Surg Lasers 33:58–61

    Google Scholar 

  5. Chaidaroon W, Wattananikorn S (2003) Conjunctival autograft transplantation for primary pterygium. J Med Assoc Thai 86:111–115

    Google Scholar 

  6. Dadeya S, Kamlesh (2001) Intraoperative daunorubicin to prevent the recurrence of pterygium after excision. Cornea 20:172–174

    Google Scholar 

  7. Davidorf J, Davidorf F (1992) Treatment of iris melanoma with photodynamic therapy. Ophthalmic Surg 23:522–527

    CAS  PubMed  Google Scholar 

  8. Diestelhorst M, Grisanti S (2002) Photodynamic therapy to control fibrosis in human glaucomatous eyes after trabeculectomy: a clinical pilot study. Arch Ophthalmol 120:130–134

    Google Scholar 

  9. Dougherty PJ, Hardten DR, Lindstrom RL (1996) Corneoscleral melt after pterygium surgery using a single intraoperative application of mitomycin-C. Cornea 15:537–540

    Google Scholar 

  10. Dougherty TJ (2002) An update on photodynamic therapy applications. J Clin Laser Med Surg 20:3–7

    Article  Google Scholar 

  11. Frucht-Pery J, Siganos CS, Ilsar M (1996) Intraoperative application of topical mitomycin C for pterygium surgery. Ophthalmology 103:674–677

    Google Scholar 

  12. Fujitani A, Hayasaka S, Shibuya Y, Noda S (1993) Corneoscleral ulceration and corneal perforation after pterygium excision and topical mitomycin C therapy. Ophthalmologica 207:162–164

    Google Scholar 

  13. Gohto Y, Obana A, Kanai M, Nagata S, Miki T, Nakajima S (2000) Photodynamic therapy for corneal neovascularization using topically administered ATX-S10 (Na). Ophthalmic Surg Lasers 31:55–60

    Google Scholar 

  14. Grimes PA, Stone RA, Laties AM, Li W (1982) Carboxyfluorescein. A probe of the blood-ocular barriers with lower membrane permeability than fluorescein. Arch Ophthalmol 100:635–639

    Google Scholar 

  15. Grisanti S, Diestelhorst M, Heimann K, Krieglstein G (1999) Cellular photoablation to control postoperative fibrosis in a rabbit model of filtration surgery. Br J Ophthalmol 83:1353–1359

    Google Scholar 

  16. Grisanti S, Gralla A, Maurer P, Diestelhorst M, Krieglstein G, Heimann K (2000) Cellular photoablation to control postoperative fibrosis in filtration surgery: in vitro studies. Exp Eye Res 70:145–152

    Google Scholar 

  17. Hill RA, Crean DH, Doiron DR, McDonald TJ, Liaw LH, Ghosheh F, Hamilton A, Berns MW (1997) Photodynamic therapy for antifibrosis in a rabbit model of filtration surgery. Ophthalmic Surg Lasers 28: 574–581

    Google Scholar 

  18. Hofmann J, Sernetz M (1983) A kinetic study on the enzymatic hydrolysis of fluorescein diacetate and fluorescein-di-beta-d-galactopyranoside. Anal Biochem 131:180–186

    Google Scholar 

  19. Kraut A, Drnovsek-Olup B (1996) Instillation of mitomycin C after recurrent pterygium surgery. Eur J Ophthalmol 6:264–267

    Google Scholar 

  20. Lam DS, Wong AK, Fan DS, Chew S, Kwok PS, Tso MO (1998) Intraoperative mitomycin C to prevent recurrence of pterygium after excision: a 30-month follow-up study. Ophthalmology 105:901–905

    Google Scholar 

  21. Maldonado MJ, Cano-Parra J, Navea-Tejerina A, Cisneros AL, Vila E, Menezo JL (1995) Inefficacy of low-dose intraoperative fluorouracil in the treatment of primary pterygium. Arch Ophthalmol 113:1356–1357

    Google Scholar 

  22. Manning CA, Kloess PM, Diaz MD, Yee RW (1997) Intraoperative mitomycin in primary pterygium excision. A prospective, randomized trial. Ophthalmology 104:844–848

    Google Scholar 

  23. Oguz H, Basar E, Gurler B (1999) Intraoperative application versus postoperative mitomycin C eye drops in pterygium surgery. Acta Ophthalmol Scand 77:147–150

    Google Scholar 

  24. Pikkel J, Porges Y, Ophir A (2001) Halting pterygium recurrence by postoperative 5-fluorouracil. Cornea 20:168–171

    Google Scholar 

  25. Raab O (1900) Ueber die Wirkung floureszierender Stoffe auf Infusorien. Z Biol 39:524–546

    Google Scholar 

  26. Rotman B, Papermaster BW (1966) Membrane properties of living mammalian cells as studied by enzymatic hydrolysis of fluorogenic esters. Proc Natl Acad Sci U S A 55:134–141

    Google Scholar 

  27. Rubinfeld RS, Pfister RR, Stein RM, Foster CS, Martin NF, Stoleru S, Talley AR, Speaker MG (1992) Serious complications of topical mitomycin-C after pterygium surgery. Ophthalmology 99:1647–1654

    Google Scholar 

  28. Rubinfeld RS, Stein RM (1997) Topical mitomycin-C for pterygia: is single application appropriate? Ophthalmic Surg Lasers 28:662–669

    Google Scholar 

  29. Safianik B, Ben-Zion I, Garzozi HJ (2002) Serious corneoscleral complications after pterygium excision with mitomycin C. Br J Ophthalmol 86:357–358

    Google Scholar 

  30. Saifuddin S, el Zawawi A (1995) Scleral changes due to mitomycin C after pterygium excision: a report of two cases. Indian J Ophthalmol 43:75–76

    Google Scholar 

  31. Simona F, Anastasi-Forni C, Benedetti C, Failla FG, Rossi FM, Meyer U (1994) Adjuvant treatment with mitomycin eyedrops after pterygium excision: Ticino experience. Klin Monatsbl Augenheilkd 204:409–412

    Google Scholar 

  32. Singh G, Wilson MR, Foster CS (1988) Mitomycin eye drops as treatment for pterygium. Ophthalmology 95:813–821

    Google Scholar 

  33. Sridhar MS, Bansal AK, Rao GN (2002) Surgically induced necrotizing scleritis after pterygium excision and conjunctival autograft. Cornea 21:305–307

    Google Scholar 

  34. Tsai YY, Lin JM, Shy JD (2002) Acute scleral thinning after pterygium excision with intraoperative mitomycin C: a case report of scleral dellen after bare sclera technique and review of the literature. Cornea 21:227–229

    Google Scholar 

  35. Urbach F, Forbes PD, Davies RE, Berger D (1976) Cutaneous photobiology: past, present and future. J Invest Dermatol 67:209–224

    Google Scholar 

  36. Van Tenten Y, Schuitmaker HJ, De Groot V, Willekens B, Vrensen GF, Tassignon MJ (2002) A preliminary study on the prevention of posterior capsule opacification by photodynamic therapy with bacteriochlorin a in rabbits. Ophthalmic Res 34:113–118

    Google Scholar 

  37. Wilson CA, Saloupis P, Hatchell DL (1991) Treatment of experimental preretinal neovascularization using photodynamic thrombosis. Invest Ophthalmol Vis Sci 32:2530–2535

    Google Scholar 

  38. Wong VA, Law FC (1999) Use of mitomycin C with conjunctival autograft in pterygium surgery in Asian-Canadians. Ophthalmology 106:1512–1515

    Google Scholar 

Download references

Acknowledgements

The authors have no proprietary or financial interest. No grants or funds were received in support of the study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Arno Hueber.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hueber, A., Grisanti, S. & Diestelhorst, M. Photodynamic therapy for wound-healing modulation in pterygium surgery. A clinical pilot study. Graefe's Arch Clin Exp Ophthalmol 243, 942–946 (2005). https://doi.org/10.1007/s00417-004-1114-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-004-1114-5

Keywords

Navigation